$216.44 2.2%
IQV Stock Price vs. AI Score
Data gathered: October 25

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About IQVIA

North Carolina-based IQVIA Holdings, Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry. The company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.


IQVIA
Price $216.44
Target Price Sign up
Volume 85,830
Market Cap $38.6B
Year Range $206.81 - $259.1
Dividend Yield 0%
PE Ratio 27.53
Analyst Rating 90% buy
Earnings Date October 31 '24
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q2 '243.81B3.03B863M363M817M2.640
Q1 '243.57B2.97B827M288M788M2.540
Q4 '233.68B4.03B-1.06B469M875M2.840
Q3 '233.56B2.96B862M303M857M2.490
Q2 '233.56B2.95B850M297M823M2.430

Insider Transactions View All

Sherbet Eric filed to sell 19,536 shares at $246.3.
August 29 '24
BOUSBIB ARI filed to sell 796,752 shares at $251.
March 4 '24
BOUSBIB ARI filed to sell 812,169 shares at $250.1.
March 4 '24
STAUB W RICHARD filed to sell 15,945 shares at $249.1.
March 4 '24
STAUB W RICHARD filed to sell 18,013 shares at $248.3.
March 4 '24

Congress Trading View All

Politician Filing Date Type Size
Rohit Khanna
Democrat
Jun 5, 24 Sell $1K - $15K
Rohit Khanna
Democrat
May 6, 24 Buy $1K - $15K
Rohit Khanna
Democrat
Mar 6, 24 Buy $1K - $15K

What is the Market Cap of IQVIA?

The Market Cap of IQVIA is $38.6B.

What is IQVIA's PE Ratio?

As of today, IQVIA's PE (Price to Earnings) ratio is 27.53.

When does IQVIA report earnings?

IQVIA will report its next earnings on October 31 '24.

What is the current stock price of IQVIA?

Currently, the price of one share of IQVIA stock is $216.44.

How can I analyze the IQV stock price chart for investment decisions?

The IQV stock price chart above provides a comprehensive visual representation of IQVIA's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling IQVIA shares. Our platform offers an up-to-date IQV stock price chart, along with technical data analysis and alternative data insights.

Does IQV offer dividends to its shareholders?

As of our latest update, IQVIA (IQV) does not offer dividends to its shareholders. Investors interested in IQVIA should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of IQVIA?

Some of the similar stocks of IQVIA are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.